Adhera Therapeutics Inc. $ATRX – end of day report for September 13, 2021
Close:
0.168
Change:
47%
$ATRX Adhera Therapeutics Provides Insight on Corporate Strategy, Development of Parkinson’s Disease and Type 1 Diabetes Drugs
on September 13, 2021
News
and Tags: Adhera Therapeutics Inc., Adhera Therapeutics Inc. News, ATRX, ATRX News
with 0 comments
Time:
10:27 AM
Symbol:
ATRX
Company:
Adhera Therapeutics Inc.
Source:
GlobeNewswire News Releases
$ATRX Adhera Therapeutics Appoints Dr. Andrew Reaume to Board of Directors
on September 9, 2021
News
and Tags: Adhera Therapeutics Inc., Adhera Therapeutics Inc. News, ATRX, ATRX News
with 0 comments
Time:
9:05 AM
Symbol:
ATRX
Company:
Adhera Therapeutics Inc.
Source:
GlobeNewswire News Releases
$ATRX Adhera Therapeutics Signs Exclusive License Agreement with Melior Pharmaceuticals I for New Type 1 Diabetes Drug Candidate
on August 24, 2021
News
and Tags: Adhera Therapeutics Inc., Adhera Therapeutics Inc. News, ATRX, ATRX News
with 0 comments
Time:
9:20 AM
Symbol:
ATRX
Company:
Adhera Therapeutics Inc.
Source:
GlobeNewswire News Releases